Abdominal obesity, adiposopathy, inflammation and cardiovascular disease risk management

By The International Chair on Cardiometabolic Risk

Dr. Jean-Pierre Després, Dr. Marja-Riitta Taskinen, Dr. Christie Ballantyne and Dr. Philip Barter begin this round table by discussing the relationships between inflammation, abdominal obesity and cardiovascular disease. Dr. Taskinen speaks about clinical tools which can be used to determine inflammation. Dr. Ballantyne therafter explains the notion of adiposopathy and how to manage inflammation. Dr. Barter explains that inflammation originating from abdominal fat cells is linked to type 2 diabetes and cardiovascular disease. In this context, data have demonstrated that physical activity/exercise is important to tackle the risk of type 2 diabetes even in the absence of weight loss. The panel follows the discussion talking about the confusion generated around the low fat diets which did not achieve the expected weight loss. The experts suggest that one should eat less and move more and that the success of maintaining weight loss is the compliance with the dietitian and kinesiologist visits.

Category:

People & Blogs

Tags:

• Inflammation;
• Abdominal
• Obesity;
• Body
• Fat
• Distribution;
• Cardiovascular
• Disease;
• my
• healthy
• waist;